Back
Global X Nasdaq 100 ESG Covered Call ETF Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
39
QYLE
Global X Nasdaq 100 ESG Covered Call ETF
Last Price:
27.70
Seasonality Move:
5.33%
Buy
71
MDGL
Madrigal Pharmaceuticals
Last Price:
320.26
Seasonality Move:
31.67%
Sell
39
Global X Nasdaq 100 ESG Covered Call ETF (QYLE)
is a Sell
Is Global X Nasdaq 100 ESG Covered Call ETF a Buy, Sell or Hold?
- The current Global X Nasdaq 100 ESG Covered Call ETF [QYLE] share price is $27.25. The Score for QYLE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- QYLE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QYLE Stock Price Chart
What is Global X Nasdaq 100 ESG Covered Call ETF's stock price today?
-
The Global X Nasdaq 100 ESG Covered Call ETF share price today is $27.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QYLE is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $259.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
QYLE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 45.42 | Sell |
Chaikin Money Flow: | -823 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.45 | Buy |
Relative Strength Index (14 RSI): | 74.74 | Buy |
Chaikin Money Flow: | 898979 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
QYLE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.5 | Sell |
20-day SMA: | 27.53 | Sell |
50-day SMA: | 27.22 | Buy |
200-day SMA: | 26.74 | Buy |
8-day EMA: | 27.49 | Sell |
20-day EMA: | 27.47 | Sell |
50-day EMA: | 27.25 | Sell |
200-day EMA: | 26.75 | Buy |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 216.22 | Buy |
20-day SMA: | 214.16 | Buy |
50-day SMA: | 227.04 | Buy |
200-day SMA: | 240.71 | Buy |
8-day EMA: | 223.2 | Buy |
20-day EMA: | 218.42 | Buy |
50-day EMA: | 226.38 | Buy |
200-day EMA: | 233.63 | Buy |
Global X Nasdaq 100 ESG Covered Call ETF Earnings Growth & QYLE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $3.75 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.12 per share, and an increase next year of $8.67 per share.
Global X Nasdaq 100 ESG Covered Call ETF Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |